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Recent studies have suggested that the
alpha 7-nicotinic receptor gene (CHRNA7)
may play a role in the pathogenesis of
schizophrenia. The alpha 7-nicotinic recep-
tor gene (CHRNA7) is involved in P50
auditory sensory gating deficits, and the
genomic locus for this gene lies in the
chromosome 15q13–14 regions. The human
gene is partially duplicated (exons 5–10)
with four novel upstream exons. The marker
D15S1360 has been shown to be significantly
linked with the phenotype of abnormal P50
suppression in schizophrenia families. The
marker L76630 is 3 kb in the 30 direction
from the last exon of the CHRNA7 gene and
is located in the duplicated region. The
function of the two L76630 copies is
unknown. We genotyped three polymorphic
markers D15S1360, D15S165, and L76630
that are localized in a genomic fragment
containing the CHRNA7 in 31 Azorean
schizophrenia families/trios (including 41
schizophrenia individuals and 97 unaf-
fected families members). An overall analy-
sis utilizing the family-based association
test revealed significant linkage disequili-
brium between L76630 and schizophrenia
(P¼0.0004). Using the extended transmis-
sion disequilibrium test and limiting the
analysis to one triad per family, transmis-
sion disequilibrium of D15S1360 was near
significance (P¼0.078). The 15q13 region
overlaps with the location of two well-
known genomically imprinted disorders:
Angelman syndrome and Prader-Willi syn-
drome. Therefore, we investigated maternal
and paternal meioses. We found significant
transmission disequilibrium for D15S1360
through paternal transmission (P¼0.0006)
in our schizophrenia families. The L76630
marker showed a significant disequilib-
rium in maternal transmissions (P¼0.028).
No parent-of-origin effect was found in
D15S165. Overall, our results suggest that
the CHRNA7 may play a role in schizophre-
nia in these families. A parent of origin
effect may be present and requires further
study. Published 2001 Wiley-Liss, Inc.{
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INTRODUCTION
Recent studies have suggested that the alpha
7-nicotinic receptor gene (CHRNA7) located in the
15q13–14 region may play a role in the pathogenesis of
schizophrenia [Freedman et al., 1997; Faraone et al.,
1998; Gejman et al., 1998; Owen et al., 1998]. Stronger
genetic evidence shows that the alpha 7-nicotinic
receptor gene (CHRNA7) is involved in the P50
auditory sensory gating deficit phenotype [Freedman
et al., 1997]. CHRNA7 has a complicated genomic
structure. The gene has 10 exons that are conserved
across chicken and other mammalian species. The
human gene is partially duplicated (exons 5–10) with
four novel upstream exons. The duplication lies within
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0.5 cM of CHRNA7, and the duplicated sequence is
expressed in the brain. CHRNA7 is also a reasonable
candidate gene for schizophrenia because of the high
incidence of smoking in schizophrenics [De Leon et al.,
1995], with both nicotine [Adler et al., 1993] and
clozapine [Nagamoto et al., 1996] ameliorating the
sensory gating deficit. Freedman et al. [1997] reported
an initial linkage for the neurophysiological phenotype
associated with schizophrenia to the genetic marker
D15S1360 at chromosome 15q13–14 in nine Utah
families, generating a LOD of 5.3 when tested against
the sensory gating phenotype and 1.33 when tested
against schizophrenia. Data from South African Bantu
families in a dense map of markers at 1 cM intervals
around D15S1360 showed some evidence in support of
this finding, with positive NPLZ results across the
entire map [Riley et al., 2000]. Extended transmission
disequilibrium testing (ETDT) [Sham and Curtis, 1995]
gave an allele-wise and genotype-wise chi-square of
6.59 (2 and 3 df; P0.037) for D15S1360; analyses with
TRANSMIT [Clayton, 1999; Clayton and Jones, 1999]
gave evidence for haplotype transmission disequili-
brium with a global chi-square of 10.647 (4 df;
P0.007) and a maximum chi-square of 6.567 (1 df;
P0.004) for marker D15S1360 [Riley et al., 2000].
Leonard et al. [1998] studied 29 families with at least
one sibling pair concordant for schizophrenia, along
with two parents or another affected relative outside
the nuclear family. Sibling pair analysis revealed a
significant proportion of D15S1360 alleles shared
identical-by-descent (P<0.0024). Leonard et al. [1998]
reported a low positive score at D15S1360 in the NIMH
Genetics Initiative Schizophrenia families (Z1.5;
y 0.0; P< 0.002). The NIMH Genetics Initiative
investigators independently published a replication
with a multipoint linkage score derived from markers
in the region; the Z-score was higher for African
American than for European American families in the
sample [Kaufmann et al., 1998]. The study by Freed-
man et al. [2001] has failed to link D15S1360 to
schizophrenia in their African American and European
American samples. However, they showed significant
genotype-wise transmission disequilibrium at D15S165
for the entire sample. Two studies have failed to find
any evidence for involvement of this locus in five
families from eastern Canada [Neves-Pereira et al.,
1998] and 54 families from the Maryland sample
[Curtis et al., 1999].
In view of these findings, we examined three
polymorphic markers (D15S1360, D15S165, and
L76630) that are localized in a genomic fragment
containing the CHRNA7 in 31 schizophrenia families/
trios (including 41 schizophrenia individuals and 97
unaffected families members) to investigate the poten-
tial association between the alpha 7-nicotinic receptor
gene (CHRNA7) and schizophrenia in Azorean families.
MATERIALS AND METHODS
Ascertainment
The families meeting inclusion criteria had a mini-
mum of two affected members. Probands were identi-
fied from the psychiatric services of the S. Miguel
(Azores Islands) [Pato et al., 1997]. All probands and all
available first- and second-degree relatives were admi-
nistered the Diagnostic Interview for Genetic Studies
(DIGS) (National Institute of Mental Health Molecular
Genetics Initiative, 1992 [Nurnberger et al., 1994])
Portuguese version [Azevedo et al., 1993] by a clinician
with extensive training in this interview. Data from the
DIGS, for each subject, was compared with medical
records and information from close relatives. All data
were entered in the OPCRIT system. The OPCRIT
facilitates a polydiagnostic approach to the diagnosis of
major psychotic and mood disorders [McGuffin et al.,
1991]. For each subject, two blind raters not involved in
the assessment of these families produced the final
diagnosis; if these are not concordant, the head of the
diagnostic panel blindly reviews and serves as the tie
breaker. Consensus was arrived at through a best-
estimate diagnosis process.
Study Samples
Our group has been studying the genetics of
psychotic disorders in a sample with reduced hetero-
geneity derived from mainland Portugal and Azores,
Portugal [Pato et al., 1997]. Surname analysis of the
population showed a 79-fold reduction in variability in
surnames for the Azorean population and a 55-fold
reduction in variability in surnames for the continental
Portuguese population, in comparison to a U.S. urban
population. These analyses are suggestive of a much
higher degree of genetic homogeneity in the Portuguese
population and especially in the geographically isolated
Azorean and Madeiran population [Pato et al., 2000].
For this study, our overall sample consists of 31
schizophrenia families/trios, including 41 schizophre-
nia individuals and 97 unaffected family members from
the Azorean families.
Extraction of Genomic DNA
Blood samples were collected in anonymously identi-
fied 10 ml Vacutainer tubes (Becton Dickinson). DNA
was prepared by a modified SDS/Proteinase K proce-
dure [Gusella et al., 1979]. About 10 ml were diluted
with three volumes of cold Miller RBCL (155 mM
NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA). Diluted
blood was kept on ice for 30 min and centrifuged at
2,500 rpm for 15 min at 48C. The pellet was well
resuspended in 30 ml of cold Miller RBCL and
centrifuged at the same speed. The pellet was well
resuspended in 5 ml of SE buffer (75 mM NH4Cl, 25 mM
Na2EDTA), 30 ml of proteinase K (20 mg/mL), 500 ml of
20% SDS was added, and the suspension was mixed
until it appeared clear and viscous; the tube was
incubated overnight at 428C with gentle rocking. Next,
the overnight suspension was added to 3 mL of 8 M
ammonium acetate and centrifuge at 3,500 rpm for 10
min. The supernatant was transferred to a new Falcon
tube, and 2 volumes of ice-cold absolute ethanol were
added. The DNA was picked off, washed twice in 70%
ethanol, partially air-dried, and slowly solubilized in
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1TE with RNase at 48C. Concentration and purity
were evaluated with a spectrophotometer. A 260/280
nm ratio of 1.8 to 1.9 was usually obtained and the final
concentration was adjusted to 100 mg/ml.
Genotyping
Three dinucleotide repeat polymorphic markers
D15S1360, D15S165, and L76630, which are localized
in a genomic fragment containing the CHRNA7
[Beckmann et al., 1993; Freedman et al., 1997], were
tested. Oligonucleotide primer sequences for each
polymorphism are shown in Table I. For PCR-based
DNA markers, primer sets were synthesized in Roswell
Park Cancer Institute Biopolymer Facility. The PCR
was performed in a total volume of 20 ml containing the
following: 40 ng genomic DNA; 200 mM each of dATP,
dGTP, dTTP, and dCTP; 50 mM KCl; 10 mM Tris-HCl
(pH 8.3); 1.5 mmol MgCl2; 10 pmol of each primer (for
detection of radioactivity, one primer per pair was
labeled with 32P g-ATP by using the T4 polynucleotide
kinase forward reaction), and 0.5 units Taq polymerase.
PCR condition is under an initial denaturation at 948C
for 5 min; 27 cycles were repeated with denaturation at
948C for 30 sec, the different annealing temperature for
respective marker (Table I) for 75 sec, extension at 758C
for 15 sec. A final synthesis step consists of 5 min at
728C. After PCR, 5 ml of 95% formamide dye was added
to each sample, which was then heated to 908C for 5
min. The samples were then cooled on ice prior to
loading on a 6% polyacrylamide/urea sequencing gel.
The gel was run at 65 W for approximately 2–4 hr.
After electrophoresis, the gel was dried and autoradio-
graphed. Genotypes were confirmed by independent
reading of the electropherograms by at least two
individuals. Data were analyzed by family-based
association test (FBAT) [Lake et al., 2000] and ETDT
[Sham and Curtis, 1995].
Statistical Analysis
Our current sample includes both parents/proband
trios and extended families, making the statistical
analysis more complex. In fact, a simple and straight-
forward approach like the transmission/disequilibrium
test is not applicable in extended families, since marker
genotypes among siblings are correlated in linked
regions. Thus, to detect a possible correlation between
genotype and phenotype, we decided to use as primary
analysis the FBAT procedure [Lake et al., 2000], which
tests for association in the presence of linkage and
generalizes the transmission disequilibrium test to any
kind of family. The FBAT method is a valid test for the
null hypothesis of no linkage and no association.
However, we did not previously test for linkage to
chromosome 15 and, given the cautionary statement of
Lake et al. [2000], we also evaluated the presence of
association with the ETDT program [Sham and Curtis,
1995] at the expense of reducing the power of our
sample by analyzing only one parents/proband trio
from each extended family.
RESULTS
We tested the relationship between CHRNA7 and
schizophrenia using the family-based association test
[Lake et al., 2000] and the extended transmission
disequilibrium testing [Sham and Curtis, 1995] to look
for distortions in the expected patterns of allele and
genotype segregation to affected offspring. An overall
analysis utilizing the FBAT revealed significant link-
age disequilibrium between L76630 and schizophrenia
(P0.0004). Results of ETDT analysis for the three
markers D15S165, D15S1360, and L76630 in our
schizophrenia families/trios are shown in Table II.
These three markers did not exhibit linkage disequili-
brium with each other. The marker D15S1360 is <120
kb upstream from the first exon of the CHRNA7 gene,
which Freedman et al. [1997] reported highly signifi-
cant linkage with the P50 abnormality in schizophre-
nics. The analysis of the entire sample for marker
D15S1360 shows that both the allele-wise chi-square
and the genotype-wise chi-square were 6.81 (3 df;
P 0.078) for schizophrenia. For marker D15S165, the
analysis of the entire sample shows the allele-wise
chi-square was 2.56 (8 df; P 0.59) and the genotype-
wise chi-square was 13.49 (16 df; P 0.63) for schizo-
phrenia. For the duplicated marker L76630 of the
CHRNA7 gene, the analysis of the entire sample shows
that both the allele-wise and the genotype-wise chi-
square were 1.99 (df 1; P0.15) for schizophrenia.
Because of the strong evidence for imprinting in this
region of 15q, we then ran the data looking at maternal
and paternal meioses and found significant transmis-
sion disequilibrium for D15S1360 through the paternal
TABLE I. Oligonucleotide Primer Sequences and Annealing Temperature for D15S1360, L76630,
and D15S165
Marker Primer sequences
Annealing tempera-
ture
D15S1360 50-GATCTTTGGTAGAAGC-30 508C
50-ACCACCACTACCATACAGAC-30
L76630 50-TCCAGCCATCTGGCTCACTCAT-30 628C
50-CCTGAGGCTGGAATGTCCTGAT-30
D15S165 50-GTTTACGCCTCATGGATTTA-30 578C
50-GGGCACACAGTCCCAA-30
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transmission. The allele-wise chi-square was 17.54
(df 3; P 0.0006), and the genotype-wise chi-square
was 17.55 (df 3; P 0.00056). Significant transmission
disequilibrium for L76630 was found through maternal
transmission, both the allele-wise and the genotype-
wise chi-square were 4.81 (df 1; P0.028). No parent-
of-origin effect was found for D15S165 in the entire
sample of schizophrenia samples.
DISCUSSION
The FBAT was judged to be most appropriate for our
sample because of its ability to extend traditional tests
of transmission disequilibrium to a family of any
structure and with multiple affecteds. Traditional
linkage methods (parametric or nonparametric) would
have little power to detect linkage in this pilot sample
from a single Azorean island. We detected significant
linkage disequilibrium between L76630 and narrowly
defined schizophrenia (P0.0004). The other two
markers did not show significant linkage disequili-
brium with schizophrenia and there is no disequili-
brium marker to marker across all three. This may be
due to the evolutionary history of this island popula-
tion, wherein, for example, the disequilibrium between
the marker L76630 and schizophrenia may have been
skewed by population selection at the time of island
settlement. The basis for the significant disequilibrium
detected between L76630 and schizophrenia but not
detected with the other two markers may also be
related in some way to the instability and duplication in
the CHRNA7 gene area.
It is important to remember that this region of
15q13–14 shows parent-of-origin effects in genetic
transmission. To our knowledge, the results of sig-
nificant transmission disequilibrium for D15S1360
through paternal transmission (P0.0006) and for
L76630 through maternal transmission (P 0.028) in
our schizophrenia families provide the first evidence
of the parent-of-origin effect for the CHRNA7 locus.
Some suggestion of parent-of-origin effect has
been previously noted for schizophrenia. Two studies
[Ohara et al., 1997; Husted et al., 1998] found
anticipation to be greater from paternal than maternal
inheritance in schizophrenia families. Yaw et al. [1996],
on the other hand, noticed a more severe symptomatol-
ogy in maternally transmitted cases, whereas the age
at onset was not significantly higher than that in
paternally transmitted cases. McInnis et al. [1999]
found anticipation in aunt-niece/nephew, but not in
uncle-niece/nephew pairs in schizophrenia families. In
addition, Schwab et al. [1998] found evidence for
maternal transmission at the marker G-olfa on chromo-
some 18p in 12 schizophrenia families. In contrast,
negative studies for parent-of-origin effect in schizo-
phrenia have been reported by others [Asherson et al.,
1994; Thibaut et al., 1995; Gorwood et al., 1996;
Imamura et al., 1998; Valero et al., 1998; DeLisi et al.,
2000].
Genomic imprinting is the process by which only the
paternal or maternal allele of a gene is active in the
offspring. Two well-known genomically imprinted dis-
orders, Angelman syndrome (AS) and Prader-Willi
syndrome (PWS), are located at 15q11–13 and are
closely adjacent to CHRNA7. Angelman syndrome has
both paternal uniparental disomy and deletion of the
maternal 15q11–13 segments that lead to the different
array of symptoms [Knoll et al., 1990]. Similarly,
Prader-Willi syndrome is attributable to the exclusive
expression of a maternally derived 15q11–13 chromo-
somal segment, resulting from either the deletion of
that portion of the paternal chromosome or from
maternal uniparental disomy [Nicholls et al., 1989;
Lalande, 1997]. There is an unexpected high co-
occurrence of schizophrenia and Prader-Willi syndrome
[Clarke et al., 1993], perhaps because the deletion in
some cases may involve CHRNA7. Recent findings have
revealed that mutations of the imprinting center are
different in Angelman syndrome and Prader-Willi
syndrome patients. Both mutations are located in
noncoding exons and differentially regulate the switch
from maternal to paternal or paternal to maternal
epigenotype on passage through the germline [Dittrich
et al., 1996; Ferguson-Smith, 1996]. Thus, a mutation
in the same gene is expressed in different ways,
depending on whether the defect is transmitted
maternally or paternally, and this in turn depends on
whether there is differential parental methylation of
the gene.
The CHRNA7 itself has a complicated genomic
structure; the genomic locus for this gene lies in the
chromosome 15q13–14 region [Freedman et al., 1997].
The gene has 10 exons that are conserved across chick
and other mammalian species. However, the human
TABLE II. Extended Transmission Disequilibrium Test for D15S1360, D15S165, and L76630 in Schizophrenia
Marker Sample Transmission Allele-wise Genotype-wise
D15S1360 Schizophrenia Maternal 6.03, df 3, P0.11 6.03, df 3, P0.11
Paternal 17.54, df 3, P0.0006 17.55, df 3, P0.00056
Combined 6.81, df 3, P0.078 6.81, df 3, P0.078
D15S165 Schizophrenia Maternal 12.82, df 7, P 0.078 12.81, df 9, P0.17
Paternal 6.59, df 7, P0.47 12.81, df 9, P0.17
Combined 2.56, df 8, P0.59 13.49, df 16, P 0.63
L76630 Schizophrenia Maternal 4.81, df 1, P0.028 4.81, df 1, P0.028
Paternal 0.67, df 1, P0.41 0.67, df 1, P0.41
Combined 1.99, df 1, P0.15 1.99, df 1, P0.15
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gene is part of a duplicated cassette of expressed
sequences. Exons 5-10 of the alpha 7-nicotinic receptor
gene are duplicated, which are located nearly adjacent
to each other within approximately 1 Mb of DNA at
chromosome 15q14. Two copies of exons 6 and 7 and the
L76630 locus 30 of exon 10 are detected in both a somatic
cell chromosome 15 hybrid and in a single YAC
(969b11) containing the full-length gene and duplicated
CHRNA7 exons [Gault et al., 1998]. The marker
L76630 is duplicated and therefore present in two
copies, whereas markers D15S1360 and D15S165 are
not duplicated. Since duplicated sequences that are
expressed necessarily imply regulatory consequences,
such replications have been implicated in several
human genetic diseases [Lehrman et al., 1987; Den-
Dunnen et al., 1989; Hu and Worton, 1992; Campbell
et al., 1997]. If mutation is involved in the partial
duplicated locus of CHRNA7, it may cause the parent-
of-origin effect in schizophrenia by the same genetic
imprinted mechanism as Angelman syndrome and
Prader-Willi syndrome, because these three genes all
are located in the same region of chromosome 15.
Summarizing our results of parent transmission with
schizophrenia in the relatively homogeneous Portu-
guese population in the region of the CHRNA7 at
chromosome 15q13–14 would suggest that imprinting
may play a significant role in the transmission of
schizophrenia, and the partially duplicated CHRNA7
may be a susceptibility gene for genomic imprinting in
schizophrenia transmission. Since the sample of
families was collected for a linkage study without the
parent-of-origin effect in mind, there was no bias in
selecting families demonstrating either maternal or
paternal patterns of transmission. However, our sam-
ple size is not large enough to produce significant
positive finding for D15S1360 and D15S165 when
considered total transmission, which may limit the
potential validity of our finding.
Overall, our results suggest that the CHRNA7 locus
is involved in risk for the disorder. In the context of
previous reports, we are seeing an increasing number of
replications, thus more strongly implicating a role for
this gene. Our study has the limitation of a relatively
small sample size. However, the increased homogeneity
of this island population reduces unwanted population
genetic noise facilitating identification of genetic risk
signals. If we consider this to be a replication study, our
observed P value of 0.0004 can be judged as relatively
robust support for CHRNA7 as a susceptibility locus for
schizophrenia.
ACKNOWLEDGMENTS
This research was supported by NIMH grants
RO1-MH52618 and RO1-MH58693 to C.N.P., NARSAD
Independent Investigator grant to F.M., and Medical
Research Council of Canada grant MT0057 to J.L.K.
REFERENCES
Adler LE, Hoffer LD, Wiser A, Freedman R. 1993. Normalization of
auditory physiology by cigarette smoking in schizophrenic patients. Am
J Psychiatry 150:1856–1861.
Asherson P, Walsh C, Williams J, Sargeant M, Taylor C, Clements A, et al.
1994. Imprinting and anticipation: are they relevant to genetic studies
of schizophrenia? Br J Psychiatry 164:619–624.
Azevedo MH, Dourado A, Valente J, Macedo A, Coelho I, Pato M, Pato C.
1993. The Portuguese-language version of the Diagnostic Interview for
Genetic Studies. Psychiatr Genet 3:189.
Beckmann JS, Tomfohrde J, Barnes RI, et al. 1993. A linkage map of
human chromosome 15 with an average resolution of 2 cM and
containing 55 polymorphic microsatellites. Hum Mol Genet 2:2019–
2030.
Campbell L, Potter A, Ignatius J, Dubowitz D, Davies K. 1997. Genomic
Variation and gene conversion in spinal muscular atrophy: implications
for disease process and clinical phenotype. Am J Hum Genet 61:40–
50.
Clarke DJ. 1993. Prader-Willi syndrome and psychoses. Br Psychiatry
163:680–684.
Clayton D. 1999. A generalization of the transmission/disequilibrium test
for uncertain haplotype transmission. Am J Hum Genet 65:1170–
1177.
Clayton D, Jones H. 1999. Transmission disequilibrium tests for extended
marker haplotypes. Am J Hum Genet 65:1161–1169.
Curtis L, Blouin J-L, Radhakrishna U, Gehrig G, Lasseter VK, Wolyniec P,
Nestadt G, Dombroski B, Kazazian HH, Pulver AE, Housman D,
Bertrand D, Antonarakis SE. 1999. No evidence for linkage between
schizophrenia and markers at chromosome 15q13–14. Am J Med Genet
(Neuropsychiatr Genet) 88:109–112.
De Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM.
1995. Schizophrenia and smoking an epidemiological survey in a state
hospital. Am J Psychiatry 152:453–455.
DeLisi LE, Razi K, Stewart J, Relja M, Shields G, Smith AB, Wellaman N,
Larach VW, Loftus J, Vita A, Comazzi M, Crow TJ. 2000. No evidence
for a parent-of-origin effect detected in the pattern of inheritance of
schizophrenia. Biol Psychiatry 48:706–709.
Den-Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB,
Wapenaar MC, van PH, van Broeckhoven C, Pearson PL, van Ommen
GJ. 1989. Topography of the Duchenne muscular dystrophy (DMD)
gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and
13 duplications. Am J Hum Genet 45:835–847.
Dittrich B, Buiting K, Kom B, Rickard S, Buxton J, Saitoh S, Nicholls RD,
Pouska A, Winterpacht A, Zabel B, Horsthemke B. 1996. Imprint
switching on human chromosome 15 may involve alternative tran-
scripts of the SNPPN gene. Nat Genet 14:163–170.
Faraone SV, Matise T, Svrakic D, et al. 1998. Genome scan of European-
American schizophrenia pedigrees: results of the NIMH Genetics
Initiative and Millennium Consortium. Am J Med Genet 81:290–295.
Ferguson-Smith AC. 1996. Imprinting moves to the center. Nat Genet
14:119–121.
Freedman R, Coon H, Myles-Worsley M, et al. 1997. Linkage of a
neurophysiological deficit in schizophrenia to a chromosome 15 locus.
Proc Natl Acad Sci USA 94:587–592.
Freedman R, Leonard S, Gault JM, Hopkins J, Cloninger CR, Kaufmann
CA, Tsuang MT, Farone SV, Malaspina D, Svrakic DM, Sanders A,
Gejman P. 2001. Linkage disequilibrium for schizophrenia at the
chromosome 15q13–14 locus of the alpha 7-Nicotinic acetylcholine
receptor subunit gene (CHRNA7). Am J Med Genet 105:20–22.
Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, Moore T,
Jacobs S, Merriwether J, Choi MJ, Kim EL, Walton K, Buiting K, Davis
A, Breese C, Freedman R, Lenard S. 1998. Genomic organization and
partial duplication of the human 7 neuronal nicotinic acetylcholine
receptor gene. Genomics 52:173–185.
Gejman PV, Gershon ES, Zhang J, et al. 1998. Progress of genome scan of
the NIMH Intramuron schizophrenia collection. Am J Med Genet
81:453.
Gorwood P, Leboyer M, Falissard B, Jay M, Rouillon F, Feingold J. 1996.
Anticipation in schizophrenia: new light on a controversial problem.
Am J Psychiatry 153:1173–1177.
Gusella J, Varsanyi-Breiner A, Kao FT, Jones C, Puck TT, Keys C, Orkin S,
Housman D. 1979. Precise localization of human beta-globin gene
coplex on chromosome 11. Proc Natl Acad Sci USA 76:5239–5242.
Hu X, Worton RG. 1992. Partial gene duplication as a cause of human
disease. Hum Mutat 1:3–12.
Husted J, Scutt LE, Bassett AS. 1998. Paternal transmission and
anticipation in schizophrenia. Am J Med Genet 81:156–162.
Evidence for Linkage Disequilibrium 673
Imamura A, Honda S, Nakane Y, Okazaki Y. 1998. Anticipation in
Japanese families with schizophrenia. J Hum Genet 43:217–223.
Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD,
Meyer J, Zambuto CT, Schmitt K, Matise TC, Harkavy FJ, Jampe C,
Lee H, Shore D, Wynne D, Faraone SV, Tsuan MT, Cloninger CR. 1998.
NIMH genetics initiative millennium schizophrenia consortium: link-
age analysis of African-American pedigrees. Am J Med Genet 81:282–
289.
Knoll JHM, Nicholls RD, Magenis RE, Glatt K, Graham JM Jr, Kaplan L,
Lalande M. 1990. Angelman syndrome: three molecular classes
identified with chromosome 15q11–q13-specific DNA markers. Am J
Hum Genet 47:149–155.
Lake SL, Blacker D, Laird NM. 2000. Family-based tests of association in
the presence of linkage. Am J Hum Genet 67:1515–1525.
Lalande M. 1997. Parental imprinting and human disease. Ann Rev Genet
30:173–195.
Lehrman MA, Goldstein JL, Russell DW, Brown MS. 1987. Duplication of
seven exons in the LDL receptor gene caused by Alu-Alu recombination
in a subject with familial hypercholesterolemia. Cell 48:827–835.
Leonard S, Gault J, Moore T, et al. 1998. Further investigation of a
chromosome 15 locus in schizophrenia: analysis of affected sibpairs
from the NIMH Genetics Initiative. Am J Med Genet 81:308–312.
McGuffin P, Frarmer A, Harvey I. 1991. A polydiagnostic application of
operational criteria in studies of psychotic illness: development and
reliability of the OPCRIT system. Arch Gen Psychiatry 8:764–770.
McInnis MG, McMahon FJ, Crow TJ, Ross CA, DeLisi LE. 1999.
Anticipation in schizophrenia: a review and consideration. Am J Med
Genet 88:686–693.
Nagamoto HT, Adler LE, Hea RA, Griffith JM, McRae KA, Freedman R.
1996. Gating of auditory P50 in schizophrenics: unique effects of
clozapine. Biol Psychiatry 40:181–188.
Neves-Pereira M, Bassett AS, Honer WG, Lang D, King NA, Kennedy JL.
1998. No evidence for linkage of the CHRNA7 gene region in Canadian
schizophrenia families. Am J Med Genet (Neuropsychiatr Genet)
81:361–363.
Nicholls RD, Knoll JHM, Butler MG, Karam S, Lalande M. 1989. Genetic
imprinting suggested by maternal heterodisomy in non-deletion
Prader-Willi syndrome. Nature 342:281–285.
Nurnberger J, Blehar M, Kaufmann C, Yok-cooler C, Simpson S, Harkavy-
Friedman J, Severe J, Malaspina D, Reich T. 1994. Diagnostic
interview for genetic studies: rationale, unique features and training.
Arch Gen Psychiatry 51:849–859.
Ohara K, Xu HD, Mori N, Suzuki Y, Xu DS, Ohara K, Wang ZC. 1997.
Anticipation and imprinting in schizophrenia. Biol Psychiatry 42:760–
766.
Owen MJ, Craddock N. 1998. Chromosome 11 workshop. Psychiatr Genet
8:89–92.
Pato CN, Azevedo MH, Pato MT, Kennedy JL, Coelho I, Paz Ferreira C,
Dourado A, Macedo A, Valente J, Madeira J, Gago da Camara J, Moniz
M, Correia C. 1997. Selection of homogeneous populations for genetic
study: the Portugal Genetics of Psychosis Project. Am J Med Genet
(Neuropsychiatr Genet) 74:286–288.
Pato CN, Macedo A, Ambrosio A, Vincent J, Bauer A, Schindler K, Xu J,
Coelho I, Dourado A, Valente J, Azevedo MH, Kennedy J, Pato M. 2000.
Detection of expansion regions in Portuguese bipolar families. Am J
Med Genet (Neuropsychiatr Genet) 96:854–857.
Riley BP, Makoff A, Mogudi-Carter M, Jenkins T, Williamson R, Collier D,
Murray R. 2000. Haplotype transmission disequilibrium and evidence
for linkage of the CHRNA7 gene region to schizophrenia in Southern
African Bantu families. Am J Med Genet 96:196–201.
Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Ho¨nig S, Strau
M, Segman R, Lichtermann D, Knapp M, Trixler M, Maier W,
Wildenauer DB. 1998. Support for a chromosome 18p locus conferring
susceptibility to functional psychoses in families with schizophrenia,
by association and linkage analysis. Am J Hum Genet 63:1139–
1152.
Sham PC, Curtis D. 1995. An extended transmission/disequilibrium test
(TDT) for multi-allele marker loci. Am Hum Genet 59:323–336.
Thibaut F, Martinez M, Petit M, Jay M, Campion D. 1995. Further evidence
for anticipation in schizophrenia, Psychiatry Res 59:25–33.
Valero J, Martorell L, Marine J, Vilella E, Labad A. 1998. Anticipation and
imprinting in Spanish families with schizophrenia. Acta Psychiatr
Scand 97:343–350.
Yaw J, Myles-Worsley M, Hoff M, Holik J, Freedman R, Byerley W, Coon H.
1996. Anticipation in mutiplex schizophrenia pedigrees. Psychiatr
Genet 6:7–11.
674 Xu et al.
